Total amount raised
Latest funding date
Location
Title
CEO
https://www.linkedin.com/in/reshma-kewalramani-md-fasn-8328ba21
Reshma Kewalramani, MD FASN is the CEO and President at Vertex, a global biotechnology company committed to transforming the lives of people with serious diseases. Since assuming the role in April 2020, she has brought deep scientific and medical expertise to her leadership, guiding Vertex's continued growth and innovation across its pipeline and commercial portfolio.
Who is the CEO of Vertex?
Reshma Kewalramani, MD FASN is a physician-scientist and seasoned executive who has been leading Vertex as its CEO and President since April 2020.
Kewalramani's professional background spans medicine, drug development, and executive leadership. Her experience as a practicing nephrologist and her deep understanding of clinical science have shaped her approach to leading Vertex, where she focuses on advancing transformative medicines for patients with serious diseases.
Work History
- Vertex - CEO and President: April 2020 - Present
- Vertex - Executive Vice President and Chief Medical Officer: April 2018 - April 2020
- Vertex - Senior Vice President: February 2017 - April 2018
- Massachusetts General Hospital - Resident Physician: January 1998 - January 2001
Education History
Reshma Kewalramani, MD FASN attended Harvard Business School, an experience that has complemented her medical training and contributed to her development as a leader at the intersection of science and business.
When did Reshma Kewalramani, MD FASN join Vertex?
Reshma Kewalramani, MD FASN assumed the role of CEO and President at Vertex in April 2020. Prior to stepping into the top leadership position, she served in several senior roles within the company, building a strong foundation in both the scientific and operational dimensions of the business.
